
Mental health researcher @KingsIoPPN @kclcfad, person who has not yet grasped social media or the internet.
- Tweets241
- Following322
- Followers276
- Likes596

ALT Final summary – what do we know? Aberrant inflammatory biomarkers present in a subset of, but not all, people with depression May be more so in people with TRD Specific anti-inflammatory medications heralded for treatment promise ?for those with elevated pro-inflammatory markers Antidepressants not specifically anti-inflammatory, especially in non-responders Inflammation associated with other relevant factors e.g., cognition, somatic symptoms – multimodal examinations may be fruitful Inflammation may still be promising markers for treatment stratification

ALT Inflammation & TRD: potential translation from bench to bedside? Dr Rebecca Strawbridge, LECTURER IN Affective Disorders, IoPPN, KCL. [email protected]























